User login
Key clinical point: Women presenting with multiple sclerosis (MS) are more likely to develop trigeminal neuralgia (TN) relative to men with MS.
Major finding: The estimated pooled TN prevalence in the overall population was 3.4%, with the prevalence being greater among women with MS (3.8%; 95% CI, 0.8%-8.7%) than among men with MS (2.4%; 95% CI, 0.5%-5.4%).
Study details: Findings are from a meta-analysis of 19 studies involving 30,348 patients with MS.
Disclosures: This study reported no funding source or conflict of interests.
Source: Houshi S et al. Mult Scler Relat Disord. 2021 Dec 28. doi: 10.1016/j.msard.2021.103472.
Key clinical point: Women presenting with multiple sclerosis (MS) are more likely to develop trigeminal neuralgia (TN) relative to men with MS.
Major finding: The estimated pooled TN prevalence in the overall population was 3.4%, with the prevalence being greater among women with MS (3.8%; 95% CI, 0.8%-8.7%) than among men with MS (2.4%; 95% CI, 0.5%-5.4%).
Study details: Findings are from a meta-analysis of 19 studies involving 30,348 patients with MS.
Disclosures: This study reported no funding source or conflict of interests.
Source: Houshi S et al. Mult Scler Relat Disord. 2021 Dec 28. doi: 10.1016/j.msard.2021.103472.
Key clinical point: Women presenting with multiple sclerosis (MS) are more likely to develop trigeminal neuralgia (TN) relative to men with MS.
Major finding: The estimated pooled TN prevalence in the overall population was 3.4%, with the prevalence being greater among women with MS (3.8%; 95% CI, 0.8%-8.7%) than among men with MS (2.4%; 95% CI, 0.5%-5.4%).
Study details: Findings are from a meta-analysis of 19 studies involving 30,348 patients with MS.
Disclosures: This study reported no funding source or conflict of interests.
Source: Houshi S et al. Mult Scler Relat Disord. 2021 Dec 28. doi: 10.1016/j.msard.2021.103472.